Full text is available at the source.
Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease
How Aging Science May Influence Treatments for Heart Disease in Older Adults
AI simplified
Abstract
Geroscience suggests that cardiovascular disease (CVD) may stem from a decline in mechanisms that counteract age-related molecular damage.
- Cardiovascular disease is often linked to multimorbidity and frailty in older patients.
- Aging negatively impacts prognosis and treatment responses for CVD.
- Resilience mechanisms in aging may influence the development and progression of CVD.
- Gerotherapeutics aim to enhance these resilience mechanisms to prevent chronic diseases and improve overall healthspan.
- Some gerotherapeutic strategies are already being utilized in CVD management, indicating their potential to transform patient care.
AI simplified